Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metabolic Syndrome × Walking × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 12 Breast Neoplasms 9 Fatigue 7 Neoplasms 6 Lung Neoplasms 2 Colonic Neoplasms 2 Cognitive Dysfunction 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Postoperative Bowel Functions 1 Polycystic Ovary Syndrome 1 Parasomnias 1 Obesity 1 Multiple Endocrine Neoplasia Type 1 1 Metabolic Syndrome 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Asthenia 1 Arthritis 1 Arthralgia 1 Adenomatous Polyps 1

Interventions

Metformin 7 Pioglitazone 2 Magnetic Resonance Spectroscopy 2 Inositol 2 Exercise 2 Blood Pressure 2 semaglutide 1 maltodextrin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Walking 1 Vascular Stiffness 1 Triptorelin Pamoate 1 Topiramate 1 Tirzepatide 1 Testosterone 1 Spironolactone 1 Qsymia 1 Pyruvic Acid 1 Pulse Wave Analysis 1 Phlebotomy 1 Phentermine 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Observation 1 Naltrexone 1 Medical History Taking 1 Liraglutide 1 Leuprolide 1 Human Growth Hormone 1 Hepatectomy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07157371 2025-09-05

SSAET

Riphah International University

Phase NA Active not recruiting

Polycystic Ovary Syndrome, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡